Posted in | News | Gold

Paget Minerals Reports Initial Equity Investment in Trident Gold, Colombia

Paget Minerals Corp. (TSX VENTURE:PGS) today announced that it has made an initial (seed) equity investment in Trident Gold Corporation, a private Colombian gold exploration company.

Trident has established operating management and technical teams in Colombia and has a diversified board of directors with the proven ability to secure, explore and develop gold deposits. Over 50,000 hectares of mineral claims in the prolific Segovia-Remedios mineral belt, near Frontino Gold Mines (Medoro Resources) and the Amalfi and Anori districts are held by Trident under joint venture option agreements where Trident holds a minimum 80% JV interest. Property evaluations of ground under option are on-going and additional properties, including an asset providing near-term production potential, are under due diligence examination for acquisition.

Paget currently holds 6% of fully-diluted Trident stock and the investment provides for an increasing percentage equity ownership in future financings as well as an avenue for direct investments in individual projects. Paget also retains one board seat.

Colombia is recognized as one of the most prospective, yet under explored countries in the world, and has emerged as an extremely attractive jurisdiction for gold exploration with senior and junior explorers realizing recent significant successes, including: Anglo Gold Ashanti (La Colosa – 11.3M ozs gold) and Ventana Gold (La Bodega – high-grade gold intersections announced).

David Volkert, President & CEO stated, "Paget's investment in Trident provides exposure to the discovery potential in Colombia and a strategic expansion and diversification to the portfolio of B.C. properties, including the Chist Creek precious-metal enriched VMS discovery, the Mt. Dunn porphyry project and the Cabin epithermal gold-silver project all announced within the last three weeks."

Source: Paget Minerals Corp.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Azthena logo powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Azthena logo with the word Azthena

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.